Effect of Risk Management in Diabetic Retinopathy

Junnan Lin; Ye Li; Lishi Luo

doi:doi:10.11648/j.ijde.20200501.12

| Peer-Reviewed

Effect of Risk Management in Diabetic Retinopathy

Junnan Lin, Ye Li, Lishi Luo

Published in International Journal of Diabetes and Endocrinology (Volume 5, Issue 1)

Received: 28 December 2019 Accepted: 6 January 2020 Published: 21 January 2020

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Objective: To evaluate the effect of risk management of nursing in diabetic retinopathy patient. Methods: 98 patients diagnosed as diabetic retinopathy from January 2018 to January 2019, they were randomly assigned to control group and intervention group, we use the different nursing measure to both of groups. Our researchers collected the data of negative patient reaction and result of serum inflammatory cytokines in before treatment and after treatment. Additionally, we collected the information associated with quality of life on participants by the short form-36 (SF-36). Result: The results of intervention group were better than the results of control group in negative patient reaction [n (%), 1 (2.0%) vs 6 (12.2%), p < 0.005]. In addition, the serum inflammatory cytokines and quality of life were improved after treatment, the improvements of intervention group were better than outcome of control group, most result of them had statistical significance (p < 0.005). Conclusion: The risk management of nursing improved the outcome of diabetic retinopathy treatment. Although improvement of negative patient reaction was non-significant in result, other aspect of patient had significantly improvement which were serum inflammatory cytokines and quality of life.

Published in	International Journal of Diabetes and Endocrinology (Volume 5, Issue 1)
DOI	10.11648/j.ijde.20200501.12
Page(s)	6-8
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2020. Published by Science Publishing Group

Keywords

Diabetic Retinopathy, Risk Management, Nursing

References

[1]	American Diabetes Association. Standards of medical care in diabetes 2018. January, vol. 41; 2018. Suppl. 1.
[2]	Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet Lond Engl. 2017, 389, 10085, 2239–2251.
[3]	International Diabetes Federation. IDF Diabetes Atlas, 8th ed. Brussels. Belgium: International Diabetes Federation. 2017.
[4]	wanga FS, Njelekela MA, Diamond MB, et al. Urban and rural prevalence of diabetes and pre-diabetes and risk factors associated with diabetes in Tanzania and Uganda. Glob Health Action. 2016, 23 (9), 31440.
[5]	Agarwal P, Jindal A, Sainiv K, Jindal S. Advances in diabetic retinopathy [J]. Indian J Endoainol Metab, 2014, 18 (6), 772-777.
[6]	Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015, 6 (1), 92-108.
[7]	Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA, J Am Med Assoc. 2007, 298 (8), 902-916.
[8]	Singh R, Ramasamy K, Abraham C, et al. Diabetic retinopathy: an update. Indian J Ophthalmol. 2008, 56 (3), 178-188.
[9]	National Eye Institute. Diabetic retinopathy. https://nei.nih.gov/eyedata/diabetic. Accessed 15 July 2017.
[10]	Takahashi H, Tampo H, Arai Y, Inoue Y, Kawashima H. Applying artificial intelligence to disease staging: deep learning for improved staging of diabetic retinopathy. PLoS One. 2017, 12, 87-90.
[11]	Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care. 2017, 40, 412-418.
[12]	Ip MS, Domalpally A, Sun JK, Ehrlich JS. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. Ophthalmology. 2015, 122, 367-74.
[13]	Ware JE. SF-36 health survey update. Spine. 2000, 25, 3130–3139.
[14]	Jorge R, Costa RA, Comt DC, et al. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE Study). Retina. 2006, 26, 1006-1013.
[15]	Malaguarnera G, Gagliano C, Bucolo C, et al. Lipoprotein (a) in cardiovascular diseases. BioMed Res Int. 2013, 1-5.
[16]	Tan GS, Gan A, Sabanayagam C, et al. Ethnic differences in the prevalence and risk factors of diabetic retinopathy: the singapore epidemiology of eye diseases study. Ophthalmology. 2018, 125 (4), 529–536.
[17]	Tomita M, Kabeya Y, Okisugi M, Katsuki T, Oikawa Y, Atsumi Y, et al. Diabetic microangiopathy is an independent predictor of incident diabetic foot ulcer. J Diabet Res. 2016, 5938540.

Cite This Article

Plain Text BibTeX RIS

APA Style

Junnan Lin, Ye Li, Lishi Luo. (2020). Effect of Risk Management in Diabetic Retinopathy. International Journal of Diabetes and Endocrinology, 5(1), 6-8. https://doi.org/10.11648/j.ijde.20200501.12

Copy | Download

ACS Style

Junnan Lin; Ye Li; Lishi Luo. Effect of Risk Management in Diabetic Retinopathy. Int. J. Diabetes Endocrinol. 2020, 5(1), 6-8. doi: 10.11648/j.ijde.20200501.12

Copy | Download

AMA Style

Junnan Lin, Ye Li, Lishi Luo. Effect of Risk Management in Diabetic Retinopathy. Int J Diabetes Endocrinol. 2020;5(1):6-8. doi: 10.11648/j.ijde.20200501.12

Copy | Download

@article{10.11648/j.ijde.20200501.12,
  author = {Junnan Lin and Ye Li and Lishi Luo},
  title = {Effect of Risk Management in Diabetic Retinopathy},
  journal = {International Journal of Diabetes and Endocrinology},
  volume = {5},
  number = {1},
  pages = {6-8},
  doi = {10.11648/j.ijde.20200501.12},
  url = {https://doi.org/10.11648/j.ijde.20200501.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20200501.12},
  abstract = {Objective: To evaluate the effect of risk management of nursing in diabetic retinopathy patient. Methods: 98 patients diagnosed as diabetic retinopathy from January 2018 to January 2019, they were randomly assigned to control group and intervention group, we use the different nursing measure to both of groups. Our researchers collected the data of negative patient reaction and result of serum inflammatory cytokines in before treatment and after treatment. Additionally, we collected the information associated with quality of life on participants by the short form-36 (SF-36). Result: The results of intervention group were better than the results of control group in negative patient reaction [n (%), 1 (2.0%) vs 6 (12.2%), p < 0.005]. In addition, the serum inflammatory cytokines and quality of life were improved after treatment, the improvements of intervention group were better than outcome of control group, most result of them had statistical significance (p < 0.005). Conclusion: The risk management of nursing improved the outcome of diabetic retinopathy treatment. Although improvement of negative patient reaction was non-significant in result, other aspect of patient had significantly improvement which were serum inflammatory cytokines and quality of life.},
 year = {2020}
}

Copy | Download

TY  - JOUR
T1  - Effect of Risk Management in Diabetic Retinopathy
AU  - Junnan Lin
AU  - Ye Li
AU  - Lishi Luo
Y1  - 2020/01/21
PY  - 2020
N1  - https://doi.org/10.11648/j.ijde.20200501.12
DO  - 10.11648/j.ijde.20200501.12
T2  - International Journal of Diabetes and Endocrinology
JF  - International Journal of Diabetes and Endocrinology
JO  - International Journal of Diabetes and Endocrinology
SP  - 6
EP  - 8
PB  - Science Publishing Group
SN  - 2640-1371
UR  - https://doi.org/10.11648/j.ijde.20200501.12
AB  - Objective: To evaluate the effect of risk management of nursing in diabetic retinopathy patient. Methods: 98 patients diagnosed as diabetic retinopathy from January 2018 to January 2019, they were randomly assigned to control group and intervention group, we use the different nursing measure to both of groups. Our researchers collected the data of negative patient reaction and result of serum inflammatory cytokines in before treatment and after treatment. Additionally, we collected the information associated with quality of life on participants by the short form-36 (SF-36). Result: The results of intervention group were better than the results of control group in negative patient reaction [n (%), 1 (2.0%) vs 6 (12.2%), p < 0.005]. In addition, the serum inflammatory cytokines and quality of life were improved after treatment, the improvements of intervention group were better than outcome of control group, most result of them had statistical significance (p < 0.005). Conclusion: The risk management of nursing improved the outcome of diabetic retinopathy treatment. Although improvement of negative patient reaction was non-significant in result, other aspect of patient had significantly improvement which were serum inflammatory cytokines and quality of life.
VL  - 5
IS  - 1
ER  -

Copy | Download

Author Information

Junnan Lin

Department of Ophthalmology and Stomatology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Ye Li

Department of Ophthalmology and Stomatology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Lishi Luo

Ophthalmology Department, The First Affiliated Hospital of Jinan University, Guangzhou, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Junnan Lin, Ye Li, Lishi Luo. (2020). Effect of Risk Management in Diabetic Retinopathy. International Journal of Diabetes and Endocrinology, 5(1), 6-8. https://doi.org/10.11648/j.ijde.20200501.12

Copy | Download

ACS Style

Junnan Lin; Ye Li; Lishi Luo. Effect of Risk Management in Diabetic Retinopathy. Int. J. Diabetes Endocrinol. 2020, 5(1), 6-8. doi: 10.11648/j.ijde.20200501.12

Copy | Download

AMA Style

Junnan Lin, Ye Li, Lishi Luo. Effect of Risk Management in Diabetic Retinopathy. Int J Diabetes Endocrinol. 2020;5(1):6-8. doi: 10.11648/j.ijde.20200501.12

Copy | Download

@article{10.11648/j.ijde.20200501.12,
  author = {Junnan Lin and Ye Li and Lishi Luo},
  title = {Effect of Risk Management in Diabetic Retinopathy},
  journal = {International Journal of Diabetes and Endocrinology},
  volume = {5},
  number = {1},
  pages = {6-8},
  doi = {10.11648/j.ijde.20200501.12},
  url = {https://doi.org/10.11648/j.ijde.20200501.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20200501.12},
  abstract = {Objective: To evaluate the effect of risk management of nursing in diabetic retinopathy patient. Methods: 98 patients diagnosed as diabetic retinopathy from January 2018 to January 2019, they were randomly assigned to control group and intervention group, we use the different nursing measure to both of groups. Our researchers collected the data of negative patient reaction and result of serum inflammatory cytokines in before treatment and after treatment. Additionally, we collected the information associated with quality of life on participants by the short form-36 (SF-36). Result: The results of intervention group were better than the results of control group in negative patient reaction [n (%), 1 (2.0%) vs 6 (12.2%), p < 0.005]. In addition, the serum inflammatory cytokines and quality of life were improved after treatment, the improvements of intervention group were better than outcome of control group, most result of them had statistical significance (p < 0.005). Conclusion: The risk management of nursing improved the outcome of diabetic retinopathy treatment. Although improvement of negative patient reaction was non-significant in result, other aspect of patient had significantly improvement which were serum inflammatory cytokines and quality of life.},
 year = {2020}
}

Copy | Download

TY  - JOUR
T1  - Effect of Risk Management in Diabetic Retinopathy
AU  - Junnan Lin
AU  - Ye Li
AU  - Lishi Luo
Y1  - 2020/01/21
PY  - 2020
N1  - https://doi.org/10.11648/j.ijde.20200501.12
DO  - 10.11648/j.ijde.20200501.12
T2  - International Journal of Diabetes and Endocrinology
JF  - International Journal of Diabetes and Endocrinology
JO  - International Journal of Diabetes and Endocrinology
SP  - 6
EP  - 8
PB  - Science Publishing Group
SN  - 2640-1371
UR  - https://doi.org/10.11648/j.ijde.20200501.12
AB  - Objective: To evaluate the effect of risk management of nursing in diabetic retinopathy patient. Methods: 98 patients diagnosed as diabetic retinopathy from January 2018 to January 2019, they were randomly assigned to control group and intervention group, we use the different nursing measure to both of groups. Our researchers collected the data of negative patient reaction and result of serum inflammatory cytokines in before treatment and after treatment. Additionally, we collected the information associated with quality of life on participants by the short form-36 (SF-36). Result: The results of intervention group were better than the results of control group in negative patient reaction [n (%), 1 (2.0%) vs 6 (12.2%), p < 0.005]. In addition, the serum inflammatory cytokines and quality of life were improved after treatment, the improvements of intervention group were better than outcome of control group, most result of them had statistical significance (p < 0.005). Conclusion: The risk management of nursing improved the outcome of diabetic retinopathy treatment. Although improvement of negative patient reaction was non-significant in result, other aspect of patient had significantly improvement which were serum inflammatory cytokines and quality of life.
VL  - 5
IS  - 1
ER  -

Copy | Download